Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) P/E ratio
As of 16 October 2026, Intuitive Surgical, Inc. (ISRG) trades at a P/E ratio of 48.3×. Over the past ten years it has ranged from 30.7× (October 2015) to 93.5× (January 2025); the current reading is higher than 33% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 70.7× | (11.54%) |
| FY2024 | 79.9× | 23.41% |
| FY2023 | 64.8× | (9.29%) |
| FY2022 | 71.4× | (4.87%) |
| FY2021 | 75.1× | (16.87%) |
| FY2020 | 90.3× | 82.69% |
| FY2019 | 49.4× | 2.48% |
| FY2018 | 48.2× | (23.99%) |
| FY2017 | 63.5× | 89.34% |
| FY2016 | 33.5× | (2.67%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 45.0× | (18.32%) |
| Mar 2026 | 55.1× | (22.11%) |
| Dec 2025 | 70.7× | 21.58% |
| Sep 2025 | 58.2× | (21.87%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BAX Baxter International Inc. compare | n/m |
| SOLV Solventum Corporation compare | 10.4× |
| RMD ResMed Inc. compare | 22.8× |
| ISRG Intuitive Surgical, Inc. | 48.3× |
| WST West Pharmaceutical Services, Inc. compare | 48.7× |
| ALC Alcon compare | 50.5× |
| BDX Becton, Dickinson and Company compare | 57.8× |
| RGEN Repligen Corporation compare | 234× |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement